Xiaoli Zhang1, Hanxiang Chen2, Xiao Wang3, Weiming Zhao4, Jason J Chen5. 1. Department of Microbiology, Shandong University School of Medicine, Jinan, Shandong, China; Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01532, USA. 2. Department of Microbiology, Shandong University School of Medicine, Jinan, Shandong, China. 3. Department of Pathology, Shandong University School of Medicine, Jinan, Shandong, China. 4. Department of Microbiology, Shandong University School of Medicine, Jinan, Shandong, China. Electronic address: zhaowm@sdu.edu.cn. 5. Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01532, USA; Cancer Research Center, Shandong University School of Medicine, Jinan, Shandong, China. Electronic address: Jason.chen@umassmed.edu.
Abstract
OBJECTIVES: To characterize the biological activities of LKB1, examine LKB1 protein expression and identify LKB1-regulated genes that may serve as therapeutic targets in cervical cancer. METHODS: Proliferation of cervical cancer HeLa cells expressing LKB1 was examined. LKB1 expression in normal cervical tissues and cervical cancers was assessed by immunohistochemistry. Gene expression profiles of cervical cancer HeLa cells stably expressing LKB1 were analyzed by microarray. Differentially expressed genes were analyzed using Gene Ontology (GO) terms and the Kyoto Encyclopedia of Genes and Genomes (KEGG) PATHWAY database. Quantitative RT-PCR was used to validate the microarray data. The expression of lipid phosphatase inositol polyphosphate 4-phosphatase type II (INPP4B) was confirmed by western blotting. RESULTS: Expression of LKB1 inhibited HeLa cell proliferation, activated AMPK and was lost in more than 50% of cervical carcinomas. More than 200 genes were differentially expressed between HeLa cells with and without LKB1. Bioinformatics analysis with GO annotation indicated that LKB1 plays a role in receiving diverse stimuli and converting them into molecular signals. KEGG PATHWAY analysis showed that 8 pathways were significantly regulated. These include arginine and proline metabolism and inositol phosphate metabolism. The differential expression of 7 randomly selected genes was confirmed by quantitative RT-PCR. Furthermore, the steady-state level of INPP4B protein was up-regulated in LKB1-overexpressing cells. CONCLUSIONS: This study establishes LKB1 as an important tumor suppressor in cervical cancer and sheds light on a novel signaling pathway regulated by LKB1.
OBJECTIVES: To characterize the biological activities of LKB1, examine LKB1 protein expression and identify LKB1-regulated genes that may serve as therapeutic targets in cervical cancer. METHODS: Proliferation of cervical cancerHeLa cells expressing LKB1 was examined. LKB1 expression in normal cervical tissues and cervical cancers was assessed by immunohistochemistry. Gene expression profiles of cervical cancerHeLa cells stably expressing LKB1 were analyzed by microarray. Differentially expressed genes were analyzed using Gene Ontology (GO) terms and the Kyoto Encyclopedia of Genes and Genomes (KEGG) PATHWAY database. Quantitative RT-PCR was used to validate the microarray data. The expression of lipid phosphatase inositol polyphosphate 4-phosphatase type II (INPP4B) was confirmed by western blotting. RESULTS: Expression of LKB1 inhibited HeLa cell proliferation, activated AMPK and was lost in more than 50% of cervical carcinomas. More than 200 genes were differentially expressed between HeLa cells with and without LKB1. Bioinformatics analysis with GO annotation indicated that LKB1 plays a role in receiving diverse stimuli and converting them into molecular signals. KEGG PATHWAY analysis showed that 8 pathways were significantly regulated. These include arginine and proline metabolism and inositol phosphate metabolism. The differential expression of 7 randomly selected genes was confirmed by quantitative RT-PCR. Furthermore, the steady-state level of INPP4B protein was up-regulated in LKB1-overexpressing cells. CONCLUSIONS: This study establishes LKB1 as an important tumor suppressor in cervical cancer and sheds light on a novel signaling pathway regulated by LKB1.
Authors: Y Gu; S Lin; J-L Li; H Nakagawa; Z Chen; B Jin; L Tian; D A Ucar; H Shen; J Lu; S N Hochwald; F J Kaye; L Wu Journal: Oncogene Date: 2011-06-27 Impact factor: 9.867
Authors: Hailing Cheng; Pixu Liu; Fan Zhang; Erbo Xu; Lynn Symonds; Carolynn E Ohlson; Roderick T Bronson; Sauveur-Michel Maira; Emmanuelle Di Tomaso; Jane Li; Andrea P Myers; Lewis C Cantley; Gordon B Mills; Jean J Zhao Journal: Cancer Res Date: 2013-12-09 Impact factor: 12.701
Authors: Pär Steneberg; Emma Lindahl; Ulf Dahl; Emmelie Lidh; Jurate Straseviciene; Fredrik Backlund; Elisabet Kjellkvist; Eva Berggren; Ingela Lundberg; Ingela Bergqvist; Madelene Ericsson; Björn Eriksson; Kajsa Linde; Jacob Westman; Thomas Edlund; Helena Edlund Journal: JCI Insight Date: 2018-06-21
Authors: Martina La Spina; Michele Azzolini; Andrea Salmaso; Sofia Parrasia; Eva Galletta; Marco Schiavone; Martina Chrisam; Andrea Mattarei; Giulietta Di Benedetto; Andrea Ballabio; Natascia Tiso; Mario Zoratti; Lucia Biasutto Journal: Oxid Med Cell Longev Date: 2021-12-28 Impact factor: 6.543
Authors: Thomas Rauter; Sandra Burgstaller; Benjamin Gottschalk; Jeta Ramadani-Muja; Helmut Bischof; Jesse C Hay; Wolfgang F Graier; Roland Malli Journal: Cells Date: 2020-10-17 Impact factor: 7.666